216 related articles for article (PubMed ID: 9810319)
61. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
[TBL] [Abstract][Full Text] [Related]
62. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for treatment outcome and early and late radiation reactions.
Bohr Mordhorst L; Karlsson L; Bärmark B; Sorbe B
Int J Gynecol Cancer; 2014 Sep; 24(7):1268-75. PubMed ID: 25078336
[TBL] [Abstract][Full Text] [Related]
63. Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix.
Uno T; Mitsuhashi A; Isobe K; Yamamoto S; Kawakami H; Ueno N; Usui H; Tate S; Kawata T; Ito H
Int J Gynecol Cancer; 2008; 18(1):80-4. PubMed ID: 17466053
[TBL] [Abstract][Full Text] [Related]
64. Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer.
Rietbroek RC; Bakker PJ; Schilthuis MS; Postma AJ; Zum Vörde Sive Vording PJ; Gonzalèz Gonzalèz D; Kurth KH; Bakker AJ; Veenhof CH
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):887-93. PubMed ID: 8598366
[TBL] [Abstract][Full Text] [Related]
65. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.
Perez CA; Grigsby PW; Chao KS; Mutch DG; Lockett MA
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):307-17. PubMed ID: 9607346
[TBL] [Abstract][Full Text] [Related]
66. Helical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: analysis of feasibility and early toxicity.
Marnitz S; Köhler C; Burova E; Wlodarczyk W; Jahn U; Grün A; Budach V; Stromberger C
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e137-43. PubMed ID: 21600704
[TBL] [Abstract][Full Text] [Related]
67. Radical radiotherapy with high-dose-rate brachytherapy for uterine cervix cancer long-term results.
Khor TH; Tuan JK; Hee SW; Tham IW
Australas Radiol; 2007 Dec; 51(6):570-7. PubMed ID: 17958695
[TBL] [Abstract][Full Text] [Related]
68. [Prognostic factors in the treatment of advanced cervical cancer. A retrospective study].
Sacco M; Tessa M; Rampino M; Ragona R; Airaldi C; Nassisi D; Rondi N; Gatti M; Garnero G; Rotta P
Minerva Med; 2000; 91(1-2):17-30. PubMed ID: 10858729
[TBL] [Abstract][Full Text] [Related]
69. Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: a phase I-II prospective intergroup NCOG-RTOG Study.
John M; Flam M; Sikic B; Rotman M; Cooper J; Malec M; Hannigan J; Phillips T
Gynecol Oncol; 1990 Apr; 37(1):1-5. PubMed ID: 2108909
[TBL] [Abstract][Full Text] [Related]
70. Results of radical radiotherapy in carcinoma of the uterine cervix stage I-III.
Biswal BM; Mohanti BK; Rath GK; Kumar L; Kriplani A; Ganesh T; Takkar D; Kumar S
Clin Oncol (R Coll Radiol); 1994; 6(6):356-60. PubMed ID: 7873480
[TBL] [Abstract][Full Text] [Related]
71. Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma.
Ozyar E; Yildz F; Akyol FH; Atahan IL
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):101-8. PubMed ID: 11777627
[TBL] [Abstract][Full Text] [Related]
72. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
[TBL] [Abstract][Full Text] [Related]
73. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
Kato S; Ohno T; Thephamongkhol K; Chansilpa Y; Yuxing Y; Devi CR; Bustam AZ; Calaguas MJ; de los Reyes RH; Cho CK; Dung TA; Supriana N; Mizuno H; Nakano T; Tsujii H
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):751-7. PubMed ID: 19836154
[TBL] [Abstract][Full Text] [Related]
74. High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO 2006-2007).
Niibe Y; Kenjo M; Onishi H; Ogawa Y; Kazumoto T; Ogino I; Tsujino K; Harima Y; Takahashi T; Anbai A; Tsuchida E; Toita T; Takemoto M; Yamashita H; Hayakawa K
Jpn J Clin Oncol; 2010 Aug; 40(8):795-9. PubMed ID: 20444747
[TBL] [Abstract][Full Text] [Related]
75. Interstitial thermoradiotherapy with ferromagnetic implants for locally advanced and recurrent neoplasms.
Mack CF; Stea B; Kittelson JM; Shimm DS; Sneed PK; Phillips TL; Swift PS; Luk K; Vora N; Stauffer PR
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(1):109-15. PubMed ID: 8129810
[TBL] [Abstract][Full Text] [Related]
76. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
77. A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.
Maruyama Y; Bowen MG; Van Nagell JR; Gallion HH; DePriest P; Wierzbicki J
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):529-34. PubMed ID: 8005811
[TBL] [Abstract][Full Text] [Related]
78. Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066).
Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
Int J Gynecol Cancer; 2012 Oct; 22(8):1420-6. PubMed ID: 22932262
[TBL] [Abstract][Full Text] [Related]
79. A prospective randomized study concerning the point A dose in high-dose rate intracavitary therapy for carcinoma of the uterine cervix. The final results.
Chatani M; Matayoshi Y; Masaki N; Teshima T; Inoue T
Strahlenther Onkol; 1994 Nov; 170(11):636-42. PubMed ID: 7974179
[TBL] [Abstract][Full Text] [Related]
80. Fractionation in medium dose rate brachytherapy of cancer of the cervix.
Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):907-14. PubMed ID: 8751399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
